Basic obstetric pharmacology.

Pregnancy is associated with a variety of physiological changes that can alter the pharmacokinetics and pharmacodynamics of several drugs. However, limited data exists on the pharmacokinetics and pharmacodynamics of the majority of the medications used in pregnancy. In this article, we first describe basic concepts (drug absorption, bioavailability, distribution, metabolism, elimination, and transport) in pharmacokinetics. Then, we discuss several physiological changes that occur during pregnancy that theoretically affect absorption, distribution, metabolism, and elimination. Further, we provide a brief review of the literature on the clinical pharmacokinetic studies performed in pregnant women in recent years. In general, pregnancy increases the clearance of several drugs and correspondingly decreases drug exposure during pregnancy. Based on current drug exposure measurements during pregnancy, alterations in the dose or dosing regimen of certain drugs are essential during pregnancy. More pharmacological studies in pregnant women are needed to optimize drug therapy in pregnancy.

[1]  J. Duan,et al.  Population Pharmacokinetics with a Very Small Sample Size , 2009, Drug metabolism and drug interactions.

[2]  L. Yates,et al.  Prescribing without evidence – pregnancy , 2012, British journal of clinical pharmacology.

[3]  A. Sabers.  Algorithm for lamotrigine dose adjustment before, during, and after pregnancy , 2012, Acta neurologica Scandinavica.

[4]  M. Hebert,et al.  Interpreting Tacrolimus Concentrations During Pregnancy and Postpartum , 2013, Transplantation.

[5]  M. Hudgens,et al.  Protein Binding of Lopinavir and Ritonavir During 4 Phases of Pregnancy: Implications for Treatment Guidelines , 2013, Journal of acquired immune deficiency syndromes.

[6]  S. Caritis,et al.  Pharmacokinetics of oseltamivir among pregnant and nonpregnant women. , 2011, American journal of obstetrics and gynecology.

[7]  F. Malone,et al.  Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation. , 2012, American journal of obstetrics and gynecology.

[8]  P. Fowler,et al.  Steroidogenic enzyme expression in the human fetal liver and potential role in the endocrinology of pregnancy. , 2013, Molecular human reproduction.

[9]  S. Khoo,et al.  Suboptimal Nevirapine Steady-State Pharmacokinetics During Intrapartum Compared With Postpartum in HIV-1-Seropositive Ugandan Women , 2010, Journal of acquired immune deficiency syndromes.

[10]  P. Pennell,et al.  Lamotrigine in pregnancy , 2008, Neurology.

[11]  C. Cobelli,et al.  Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical Practice , 2009, Clinical pharmacology and therapeutics.

[12]  P. Siba,et al.  Pharmacokinetic Properties of Sulfadoxine-Pyrimethamine in Pregnant Women , 2009, Antimicrobial Agents and Chemotherapy.

[13]  M. Hebert,et al.  Effect of Gestational Age on mRNA and Protein Expression of Polyspecific Organic Cation Transporters during Pregnancy , 2013, Drug Metabolism and Disposition.

[14]  Sonia Hernández-Díaz,et al.  Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. , 2011, American journal of obstetrics and gynecology.

[15]  S. Caritis,et al.  Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy. , 2005, American journal of obstetrics and gynecology.

[16]  C. Chambers,et al.  Drug Safety in Pregnant Women and Their Babies: Ignorance Not Bliss , 2008, Clinical pharmacology and therapeutics.

[17]  M. Hebert,et al.  Pharmacokinetics of Metformin during Pregnancy , 2010, Drug Metabolism and Disposition.

[18]  P. Pennell,et al.  Antiepileptic drug therapy in pregnancy I: gestation-induced effects on AED pharmacokinetics. , 2008, International review of neurobiology.

[19]  C. Falany,et al.  Developmental Expression of Aryl, Estrogen, and Hydroxysteroid Sulfotransferases in Pre- and Postnatal Human Liver , 2006, Journal of Pharmacology and Experimental Therapeutics.

[20]  S. Urien,et al.  Pharmacokinetic modelling of the placental transfer of nelfinavir and its M8 metabolite: a population study using 75 maternal-cord plasma samples. , 2007, British journal of clinical pharmacology.

[21]  M. Hebert,et al.  Contributions of human cytochrome P450 enzymes to glyburide metabolism , 2010, Biopharmaceutics & drug disposition.

[22]  K. Wisner,et al.  Lamotrigine dosing for pregnant patients with bipolar disorder. , 2013, The American journal of psychiatry.

[23]  E. Barr,et al.  Effect of pregnancy on emtricitabine pharmacokinetics , 2011, HIV medicine.

[24]  M. Hughes,et al.  Pharmacokinetics and Safety of Indinavir in Human Immunodeficiency Virus-Infected Pregnant Women , 2006, Antimicrobial Agents and Chemotherapy.

[25]  G. Anderson,et al.  Effect of Pregnancy on the Pharmacokinetics of Antihypertensive Drugs , 2009, Clinical pharmacokinetics.

[26]  P. Arck,et al.  Acetaminophen and pregnancy: short- and long-term consequences for mother and child. , 2013, Journal of reproductive immunology.

[27]  T. Tomson,et al.  Plasma concentrations of lamotrigine and its 2‐N‐glucuronide metabolite during pregnancy in women with epilepsy , 2008, Epilepsia.

[28]  R. Cavalli,et al.  Metformin pharmacokinetics in nondiabetic pregnant women with polycystic ovary syndrome , 2011, European Journal of Clinical Pharmacology.

[29]  B. Wlodarczyk,et al.  Antiepileptic drugs and pregnancy outcomes , 2012, American journal of medical genetics. Part A.

[30]  S. Kilpatrick,et al.  Influence of Body Weight, Ethnicity, Oral Contraceptives, and Pregnancy on the Pharmacokinetics of Azithromycin in Women of Childbearing Age , 2011, Antimicrobial Agents and Chemotherapy.

[31]  P. Pennell,et al.  Chapter 14 Antiepileptic Drug Therapy in Pregnancy II , 2008 .

[32]  M. Hebert,et al.  Tacrolimus placental transfer at delivery and neonatal exposure through breast milk. , 2013, British journal of clinical pharmacology.

[33]  G. Pardi,et al.  Human fetal growth and organ development: 50 years of discoveries. , 2006, American journal of obstetrics and gynecology.

[34]  L. Lewi,et al.  Pharmacokinetics of paracetamol and its metabolites in women at delivery and post-partum. , 2013, British journal of clinical pharmacology.

[35]  Chengcheng Hu,et al.  Lopinavir Tablet Pharmacokinetics With an Increased Dose During Pregnancy , 2010, Journal of acquired immune deficiency syndromes.

[36]  S. Caritis,et al.  Effect of endogenous steroid hormones on 17-alpha-hydroxyprogesterone caproate metabolism. , 2013, American journal of obstetrics and gynecology.

[37]  A. Telenti,et al.  Free and Total Plasma Levels of Lopinavir during Pregnancy, at Delivery and Postpartum: Implications for Dosage Adjustments in Pregnant Women , 2012, Antiviral therapy.

[38]  G. Hankins,et al.  Identification of glyburide metabolites formed by hepatic and placental microsomes of humans and baboons. , 2006, Biochemical pharmacology.

[39]  M. Hebert,et al.  Pharmacokinetics of doxorubicin in pregnant women , 2014, Cancer Chemotherapy and Pharmacology.

[40]  G. Hankins,et al.  Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin. , 2010, American journal of obstetrics and gynecology.

[41]  M. Klebanoff,et al.  Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth. , 2014, American journal of obstetrics and gynecology.

[42]  G. Hankins,et al.  Metabolism of 17-Alpha-Hydroxyprogesterone Caproate by Human Placental Mitochondria , 2012, Reproductive Sciences.

[43]  G. Hankins,et al.  Transfer of metformin across the dually perfused human placental lobule. , 2005, American journal of obstetrics and gynecology.

[44]  S. Urien,et al.  Pregnancy-Related Effects on Lamivudine Pharmacokinetics in a Population Study with 228 Women , 2011, Antimicrobial Agents and Chemotherapy.

[45]  T. Tomson,et al.  Effects of pregnancy and contraception on lamotrigine disposition: New insights through analysis of lamotrigine metabolites , 2008, Seizure.

[46]  M. Hebert,et al.  Pharmacokinetics and Pharmacodynamics of Atenolol During Pregnancy and Postpartum , 2005, Journal of clinical pharmacology.

[47]  E. Ben-Menachem,et al.  Pharmacokinetics of Levetiracetam during Pregnancy, Delivery, in the Neonatal Period, and Lactation , 2007, Epilepsia.

[48]  L. Calza,et al.  Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancy , 2012, Scandinavian journal of infectious diseases.

[49]  E. Capparelli,et al.  Efavirenz Pharmacokinetics During the Third Trimester of Pregnancy and Postpartum , 2012, Journal of acquired immune deficiency syndromes.

[50]  M. Hebert,et al.  Pharmacokinetics of Tacrolimus During Pregnancy , 2012, Therapeutic drug monitoring.

[51]  P. Clax,et al.  Safety and Pharmacokinetics of Nelfinavir During the Second and Third Trimesters of Pregnancy and Postpartum , 2012, HIV clinical trials.

[52]  V. Jackson,et al.  Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy , 2011, HIV medicine.

[53]  R. Ali,et al.  Gastroesophageal reflux disease in pregnancy. , 2007, Best practice & research. Clinical gastroenterology.

[54]  S. Caritis,et al.  A pharmacologic approach to the use of glyburide in pregnancy. , 2013, Obstetrics and gynecology.

[55]  T. Cressey,et al.  Pharmacokinetic Optimization of Antiretroviral Therapy in Pregnancy , 2012, Clinical Pharmacokinetics.

[56]  J. Fischer,et al.  Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[57]  Alicia B. Forinash,et al.  Drug Information Rounds Levetiracetam Use in Pregnancy , 2009, The Annals of pharmacotherapy.

[58]  R. Hines,et al.  Ontogeny of human hepatic cytochromes P450 , 2007, Journal of biochemical and molecular toxicology.

[59]  G. Hankins,et al.  Transplacental transfer and metabolism of bupropion , 2010 .

[60]  S. Caritis,et al.  Nifedipine Pharmacokinetics Are Influenced by CYP3A5 Genotype When Used as a Preterm Labor Tocolytic , 2012, American Journal of Perinatology.

[61]  D. H. Watts,et al.  Reduced indinavir exposure during pregnancy. , 2013, British journal of clinical pharmacology.

[62]  E. Perucca,et al.  Changes in Lamotrigine Pharmacokinetics during Pregnancy and the Puerperium , 2008, Therapeutic drug monitoring.

[63]  P. Swaan,et al.  ATP-Binding Cassette Transporter Expression in Human Placenta as a Function of Pregnancy Condition , 2011, Drug Metabolism and Disposition.

[64]  J. Schellens,et al.  Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[65]  G. Hankins,et al.  Transplacental transfer and distribution of pravastatin. , 2013, American journal of obstetrics and gynecology.

[66]  O. Launay,et al.  Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment. , 2009, The Journal of antimicrobial chemotherapy.

[67]  P. Narciso,et al.  Transplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant women. , 2009, Current HIV research.

[68]  S. Caritis,et al.  Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation. , 2012, American journal of obstetrics and gynecology.

[69]  Hyunyoung Jeong,et al.  Up-Regulation of UDP-Glucuronosyltransferase (UGT) 1A4 by 17β-Estradiol: A Potential Mechanism of Increased Lamotrigine Elimination in Pregnancy , 2009, Drug Metabolism and Disposition.

[70]  D. Mattison,et al.  Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide. , 2009, Biochemical pharmacology.

[71]  P. Laurberg,et al.  Iodine intake as a determinant of thyroid disorders in populations. , 2010, Best practice & research. Clinical endocrinology & metabolism.

[72]  Melinda F. Davis,et al.  Pharmacokinetics of Sertraline Across Pregnancy and Postpartum , 2008, Journal of clinical psychopharmacology.

[73]  F. Dabis,et al.  Population Pharmacokinetics of Tenofovir in HIV‐1‐Infected Pregnant Women and Their Neonates (ANRS 12109) , 2009, Clinical pharmacology and therapeutics.

[74]  S. Urien,et al.  Pregnancy-Related Effects on Tenofovir Pharmacokinetics: a Population Study with 186 Women , 2011, Antimicrobial Agents and Chemotherapy.

[75]  F. Malone,et al.  Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation. , 2011, American journal of obstetrics and gynecology.

[76]  J. Moya,et al.  A review of physiological and behavioral changes during pregnancy and lactation: Potential exposure factors and data gaps , 2014, Journal of Exposure Science and Environmental Epidemiology.

[77]  D. Mattison,et al.  Metabolism of 17alpha-hydroxyprogesterone caproate by hepatic and placental microsomes of human and baboons. , 2008, Biochemical pharmacology.

[78]  D. Havlir,et al.  Pharmacokinetics of lopinavir/ritonavir and efavirenz in food insecure HIV‐infected pregnant and breastfeeding women in tororo, uganda , 2014, Journal of clinical pharmacology.

[79]  A. Rostami-Hodjegan,et al.  Changes to methadone clearance during pregnancy , 2005, European Journal of Clinical Pharmacology.

[80]  G. Hankins,et al.  Pharmacokinetics of metronidazole in pregnant patients with bacterial vaginosis , 2011, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[81]  F. Dabis,et al.  Population Pharmacokinetics of Nevirapine in HIV-1-Infected Pregnant Women and Their Neonates , 2010, Antimicrobial Agents and Chemotherapy.

[82]  M. Mirochnick,et al.  Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum , 2008, HIV medicine.

[83]  W. Henrich,et al.  Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period , 2009, Epilepsy Research.

[84]  S. Lecoeur,et al.  The Role of the Placenta in Fetal Exposure to Xenobiotics: Importance of Membrane Transporters and Human Models for Transfer Studies , 2010, Drug Metabolism and Disposition.

[85]  S. Caritis,et al.  Identification of Enzymes Involved in the Metabolism of 17α-Hydroxyprogesterone Caproate: An Effective Agent for Prevention of Preterm Birth , 2008, Drug Metabolism and Disposition.

[86]  T. Jenkins,et al.  Influence of Gestational Age and Body Weight on the Pharmacokinetics of Labetalol in Pregnancy , 2014, Clinical Pharmacokinetics.

[87]  F. Muller,et al.  Fetal Toxic Effects of Angiotensin II Receptor Antagonists: Case Report and Follow-Up after Birth , 2005, The Annals of pharmacotherapy.

[88]  D. Haas,et al.  A pilot study of the impact of genotype on nifedipine pharmacokinetics when used as a tocolytic , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[89]  S. Z. Abdel‐Rahman,et al.  Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms. , 2010, Biochemical pharmacology.

[90]  M. Hebert,et al.  CYP2D6 Mediates 4-Hydroxylation of Clonidine In Vitro: Implication for Pregnancy-Induced Changes in Clonidine Clearance , 2010, Drug Metabolism and Disposition.

[91]  G. Hankins,et al.  Transplacental transfer of oseltamivir carboxylate , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[92]  G. Hankins,et al.  Transplacental transfer of vancomycin and telavancin. , 2012, American journal of obstetrics and gynecology.

[93]  W. L. Nelson,et al.  Clonidine Pharmacokinetics in Pregnancy , 2009, Drug Metabolism and Disposition.

[94]  M. Hebert,et al.  Atenolol Pharmacokinetics and Excretion in Breast Milk During the First 6 to 8 Months Postpartum , 2010, Journal of clinical pharmacology.

[95]  Josemir W Sander,et al.  Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy , 2010, Epilepsia.

[96]  W. Hauser,et al.  Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding , 2009, Neurology.

[97]  S. Petropoulos,et al.  Placental drug transporters and their role in fetal protection. , 2012, Placenta.

[98]  F. Amant,et al.  Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study , 2010, Acta obstetricia et gynecologica Scandinavica.

[99]  D. Mattison,et al.  Transplacental transfer and metabolism of 17-alpha-hydroxyprogesterone caproate. , 2008, American journal of obstetrics and gynecology.